The Public Service Management Unit (PSMU) conducted its annual evaluation of Kenya BioVax Institute Limited’s performance contract for 2023/24.

The Public Service Management Unit (PSMU) conducted its annual evaluation of Kenya BioVax Institute Limited’s performance contract for 2023/24.
Image link

The Public Service Management Unit conducted its annual evaluation of Kenya BioVax Institute Limited’s performance contract for 2023/24, marking a significant milestone in the institute’s journey toward becoming a leading vaccine manufacturer in Africa. The evaluation process involved a rigorous assessment of BioVax’s adherence to its key deliverables, including steps attained towards vaccine production, financial prudence, stakeholder engagement, and the implementation of the institute’s Corporate Social Responsibility (CSR) strategy.

The evaluators praised the institute’s dedication to capacity building, citing staff training programs and collaborations with international stakeholders as exemplary efforts to solidify Kenya’s place in the global vaccine manufacturing landscape.

Leave a Reply

Your email address will not be published.Required fields are marked *